Access the latest in human science and data science to accelerate results
Real World Evidence & Registries: Leverage real world evidence to support natural history studies and registries, addressing challenges of low patient numbers and difficult endpoints. Feeder registries identify patients and connect them to trial sites.
Regulatory & Genomic Expertise: Regulatory support from pre-clinical to clinical stage, the IQVIA Laboratories and genetic testing enhance patient identification, crucial for ultra-rare diseases.
Innovative Study Designs: Implement novel, adaptive, basket, and seamless study designs to improve trial efficiency and outcomes.
Accelerate Results with Integrated Capabilities and IQVIA's Connected Intelligence: Utilize IQVIA's data, actionable insights, advanced technology, and therapeutic expertise to identify the right sites, collaborate with rare disease experts, and make informed commercial decisions. Access extensive global site networks and patient advocacy relationships to enhance trial success.